This company has been marked as potentially delisted and may not be actively trading. LightWave Acquisition (LWAC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LWAC vs. CALT, ZYME, MBX, SBTX, BIOA, CYBN, WHWK, AVTE, ELYM, and OSTXShould you be buying LightWave Acquisition stock or one of its competitors? The main competitors of LightWave Acquisition include Calliditas Therapeutics AB (publ) (CALT), Zymeworks (ZYME), MBX Biosciences (MBX), Silverback Therapeutics (SBTX), BioAge Labs (BIOA), Cybin (CYBN), Whitehawk Therapeutics (WHWK), Aerovate Therapeutics (AVTE), Eliem Therapeutics (ELYM), and OS Therapies (OSTX). LightWave Acquisition vs. Its Competitors Calliditas Therapeutics AB (publ) Zymeworks MBX Biosciences Silverback Therapeutics BioAge Labs Cybin Whitehawk Therapeutics Aerovate Therapeutics Eliem Therapeutics OS Therapies Calliditas Therapeutics AB (publ) (NASDAQ:CALT) and LightWave Acquisition (NASDAQ:LWAC) are both small-cap pharmaceutical preparations industry companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation. Does the media prefer CALT or LWAC? In the previous week, Calliditas Therapeutics AB (publ) and Calliditas Therapeutics AB (publ) both had 1 articles in the media. LightWave Acquisition's average media sentiment score of 0.00 beat Calliditas Therapeutics AB (publ)'s score of -0.71 indicating that LightWave Acquisition is being referred to more favorably in the news media. Company Overall Sentiment Calliditas Therapeutics AB (publ) Negative LightWave Acquisition Neutral Is CALT or LWAC more profitable? LightWave Acquisition has a net margin of 0.00% compared to Calliditas Therapeutics AB (publ)'s net margin of -30.18%. LightWave Acquisition's return on equity of 0.00% beat Calliditas Therapeutics AB (publ)'s return on equity.Company Net Margins Return on Equity Return on Assets Calliditas Therapeutics AB (publ)-30.18% -212.04% -27.96% LightWave Acquisition N/A N/A N/A Do institutionals and insiders believe in CALT or LWAC? 2.8% of Calliditas Therapeutics AB (publ) shares are owned by institutional investors. 2.2% of Calliditas Therapeutics AB (publ) shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has preferable earnings & valuation, CALT or LWAC? LightWave Acquisition has lower revenue, but higher earnings than Calliditas Therapeutics AB (publ). CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalliditas Therapeutics AB (publ)$1.60B0.74-$43.96M-$1.85-21.62LightWave AcquisitionN/AN/AN/AN/AN/A SummaryLightWave Acquisition beats Calliditas Therapeutics AB (publ) on 4 of the 7 factors compared between the two stocks. Get LightWave Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for LWAC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LWAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LWAC vs. The Competition Export to ExcelMetricLightWave AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$299.84M$736.37M$2.41B$10.14BDividend YieldN/A4.84%13.78%4.60%P/E RatioN/A1.1725.4025.98Price / SalesN/A26.6412,660.08181.13Price / CashN/A19.5660.0160.44Price / BookN/A6.683.166.29Net IncomeN/A-$4.13M-$445.27M$271.07M LightWave Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LWACLightWave AcquisitionN/A$9.97+0.1%N/AN/A$299.84MN/A0.00N/ACALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180News CoverageZYMEZymeworks2.4361 of 5 stars$15.05+6.9%$21.43+42.4%+25.5%$1.13B$122.87M-10.03460Positive NewsMBXMBX Biosciences2.8653 of 5 stars$11.55-10.6%$37.63+225.8%N/A$388.01MN/A-2.5436News CoveragePositive NewsSBTXSilverback TherapeuticsN/A$10.07-5.8%N/A-20.6%$211.66MN/A-4.1683News CoverageHigh Trading VolumeBIOABioAge Labs0.1263 of 5 stars$4.76+1.1%N/AN/A$170.65M$3.86M0.00N/ACYBNCybin2.6883 of 5 stars$6.73+12.5%$85.00+1,163.0%N/A$158.76MN/A-1.5450News CoverageHigh Trading VolumeWHWKWhitehawk Therapeutics1.1847 of 5 stars$1.82+0.6%N/AN/A$85.30M$25.98M-30.3321AVTEAerovate TherapeuticsN/A$7.77-0.1%N/A-88.4%$77.68MN/A-2.6020Positive NewsHigh Trading VolumeELYMEliem TherapeuticsN/A$2.39+2.6%N/A-73.4%$71.11MN/A-4.519News CoverageOSTXOS Therapies2.0725 of 5 stars$2.20+5.3%$18.00+718.2%-34.6%$69.62MN/A-2.78N/AAnalyst Forecast Related Companies and Tools Related Companies CALT Competitors ZYME Competitors MBX Competitors SBTX Competitors BIOA Competitors CYBN Competitors WHWK Competitors AVTE Competitors ELYM Competitors OSTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LWAC) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LightWave Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share LightWave Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LWAC Stock Alerts